Willner & Heller, LLC
- SEC CIK
- 0001927796
- Latest filing
- Jul 7, 2026
REGN holding history
Regeneron Pharmaceuticals, Inc. in every 13F filed by Willner & Heller, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
REGN overviewAll 13F holders of REGNFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 15
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −311−100.0% | Sold out | Holders |
| Q1 2026 | 311 | $240.3K | 0.2% | −68−17.9% | Reduced | Holders |
| Q4 2025 | 379 | $292.5K | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2025 | 379 | $212.8K | 0.2% | −90−19.2% | Reduced | Holders |
| Q2 2025 | 469 | $246.3K | 0.2% | +74+18.7% | Added | Holders |
| Q1 2025 | 395 | $250.2K | 0.2% | −4−1.0% | Reduced | Holders |
| Q4 2024 | 399 | $284.2K | 0.2% | +15+3.9% | Added | Holders |
| Q3 2024 | 384 | $403.7K | 0.4% | 00.0% | Unchanged | Holders |
| Q2 2024 | 384 | $403.6K | 0.4% | 00.0% | Unchanged | Holders |
| Q1 2024 | 384 | $369.6K | 0.4% | +5+1.3% | Added | Holders |
| Q4 2023 | 379 | $332.9K | 0.4% | – | No prior filing | Holders |
| Q1 2023 | – | – | – | – | Not filed | Holders |
| Q4 2022 | 379 | $273.4K | 0.4% | −7−1.8% | Reduced | Holders |
| Q3 2022 | 386 | $266.0K | 0.4% | 00.0% | Unchanged | Holders |
| Q2 2022 | 386 | $228.0K | 0.4% | 00.0% | Unchanged | Holders |
| Q1 2022 | 386 | $244.0K | 0.3% | 00.0% | Unchanged | Holders |
| Q4 2021 | 386 | $234.0K | 0.3% | – | No prior filing | Holders |